EphB4 targeted humanized mAb-131 (Vasgene)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameEphB4 targeted humanized mAb-131 (Vasgene)
Drug Alias NameEphB4 neutralizing antibody (Vasgene)EphB4-131
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionEphrin type-B receptor 4 antagonists
TargetsEphrin type-B receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVasgene Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVasgene Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A